| Anti-inflammatory potential of Quercetin in COVID-19 treatment A Saeedi-Boroujeni, MR Mahmoudian-Sani Journal of Inflammation 18, 1-9, 2021 | 209 | 2021 |
| Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review S Heidari-Soreshjani, M Asadi-Samani, Q Yang, A Saeedi-Boroujeni Journal of nephropathology 6 (3), 254, 2017 | 90 | 2017 |
| Efficacy of a low dose of melatonin as an adjunctive therapy in hospitalized patients with COVID-19: a randomized, double-blind clinical trial G Farnoosh, M Akbariqomi, T Badri, M Bagheri, M Izadi, ... Archives of medical research 53 (1), 79-85, 2022 | 88 | 2022 |
| COVID‐19: A case for inhibiting NLRP3 inflammasome, suppression of inflammation with Curcumin? A Saeedi‐Boroujeni, MR Mahmoudian‐Sani, M Bahadoram, A Alghasi Basic & Clinical Pharmacology & Toxicology 128 (1), 37-45, 2021 | 51 | 2021 |
| miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19 S Houshmandfar, A Saeedi-Boroujeni, M Rashno, A Khodadadi, ... Naunyn-schmiedeberg's Archives of Pharmacology, 1-9, 2021 | 37 | 2021 |
| A new approach for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells MR Mahmoudian-Sani, M Asadi-Samani, T Luther, A Saeedi-Boroujeni, ... Journal of Renal Injury Prevention 6 (3), 158-163, 2017 | 31 | 2017 |
| Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19 A Saeedi-Boroujeni, MR Mahmoudian-Sani, R Nashibi, S Houshmandfar, ... Immunopharmacology and Immunotoxicology 43 (3), 247-258, 2021 | 29 | 2021 |
| Survivin as a diagnostic and therapeutic marker for thyroid cancer MR Mahmoudian-Sani, A Alghasi, A Saeedi-Boroujeni, A Jalali, ... Pathology-Research and Practice 215 (4), 619-625, 2019 | 24 | 2019 |
| MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma MR Mahmoudian-Sani, S Asgharzade, A Alghasi, A Saeedi-Boroujeni, ... Journal of Gastrointestinal Oncology 10 (4), 789, 2019 | 22 | 2019 |
| Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial A Saeedi-Boroujeni, R Nashibi, AA Ghadiri, M Nakajima, S Salmanzadeh, ... Archives of Medical Research, 2022 | 18 | 2022 |
| NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: Impact of melatonin as a medicinal supplement H Esmaeili Gouvarchin Ghaleh, A Hosseini, H Aghamollaei, ... Zeitschrift für Naturforschung C 77 (1-2), 37-42, 2022 | 18 | 2022 |
| Suppressive effects of medicinal plants and their derivatives on inflammasome complex: A systematic review MRM Sani, M Asadi-Samani, A Saeedi-Boroujeni, M Banitalebi-Dehkordi, ... International Journal of PharmTech Research 9 (6), 325-35, 2016 | 14 | 2016 |
| Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19? M Bahadoram, B Keikhaei, A Saeedi-Boroujeni, MR Mahmoudian-Sani Naunyn-schmiedeberg's Archives of Pharmacology 394, 997-1001, 2021 | 12 | 2021 |
| COVID-19-induced immunethrombocytopenic purpura;Immunopathogenesis and clinicalimplications M Bahadoram, A Saeedi-Boroujeni, S MM, H Hussaini, ... Le infezioni in medicina, 2022 | 9 | 2022 |
| Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases A Saeedi-Boroujeni, D Purrahman, A Shojaeian, ŁA Poniatowski, ... Journal of Inflammation 20 (1), 1, 2023 | 8 | 2023 |
| Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women M Jamshidi, S Mohammadi Pour, M Bahadoram, MR Mahmoudian‐Sani, ... International Journal of Gynecology & Obstetrics 153 (1), 33-44, 2021 | 8 | 2021 |
| MHC class II deficiency with normal CD4+ T cell counts: a case report F Abolnezhadian, A Saeedi-Boroujeni, S Iranparast Iranian Journal of Allergy, Asthma and Immunology, 594-600, 2018 | 8 | 2018 |
| Genetic variants and risk of thyroid cancer among Iranian patients M Jamshidi, G Farnoosh, S Mohammadi Pour, F Rafiee, ... Hormone molecular biology and clinical investigation 42 (2), 223-234, 2021 | 6 | 2021 |
| Resveratrol; an inflammasome inhibitor and a potential therapy for severe cases of COVID-19 MR Mahmoudian-Sani, AS Boroujeni, A Khodadadi, S Houshmandfar, ... Immunopathologia Persa 8 (1), e9-e9, 2021 | 6 | 2021 |
| COVID-19 Pandemic along with Pandemic of Lifestyle-Associated Diseases Victimizes Patients in an Inflammation Context! A Saeedi-Boroujeni, MR Mahmoudian-Sani Dubai Medical Journal 3 (2), 55-57, 2020 | 5 | 2020 |
